Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 20518716)

1.

New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Zaritskaya L, Shurin MR, Sayers TJ, Malyguine AM.

Expert Rev Vaccines. 2010 Jun;9(6):601-16. doi: 10.1586/erv.10.49. Review.

2.

Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials.

Zaritskaya L, Shafer-Weaver KA, Gregory MK, Strobl SL, Baseler M, Malyguine A.

J Immunother. 2009 Feb-Mar;32(2):186-94. doi: 10.1097/CJI.0b013e318197b1b2.

PMID:
19238018
3.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
4.

New approaches for monitoring CTL activity in clinical trials.

Malyguine A, Strobl S, Zaritskaya L, Baseler M, Shafer-Weaver K.

Adv Exp Med Biol. 2007;601:273-84. Review.

PMID:
17713015
5.

Immunological monitoring of cancer vaccine therapy.

Nagorsen D, Scheibenbogen C, Thiel E, Keilholz U.

Expert Opin Biol Ther. 2004 Oct;4(10):1677-84. Review.

PMID:
15461579
6.
7.
8.

A novel flow cytometric assay for evaluating cell-mediated cytotoxicity.

Burkett MW, Shafer-Weaver KA, Strobl S, Baseler M, Malyguine A.

J Immunother. 2005 Jul-Aug;28(4):396-402.

PMID:
16000959
9.

LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.

Devêvre E, Romero P, Mahnke YD.

J Immunol Methods. 2006 Apr 20;311(1-2):31-46. Epub 2006 Feb 24.

PMID:
16527300
10.

A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry.

Godoy-Ramirez K, Mäkitalo B, Thorstensson R, Sandström E, Biberfeld G, Gaines H.

Cytometry A. 2005 Dec;68(2):71-80.

11.

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.

Shafer-Weaver K, Sayers T, Strobl S, Derby E, Ulderich T, Baseler M, Malyguine A.

J Transl Med. 2003 Dec 29;1(1):14.

12.

Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.

Pass HA, Schwarz SL, Wunderlich JR, Rosenberg SA.

Cancer J Sci Am. 1998 Sep-Oct;4(5):316-23.

PMID:
9815296
13.

Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cells.

Kowalczyk DW, Wlazlo AP, Giles-Davis W, Ertl HC.

J Immunol Methods. 2000 Jul 31;241(1-2):131-9.

PMID:
10915855
14.

Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials.

Shafer-Weaver K, Rosenberg S, Strobl S, Gregory Alvord W, Baseler M, Malyguine A.

J Immunother. 2006 May-Jun;29(3):328-35.

PMID:
16699376
15.

Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.

Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.

Cell Immunol. 2009;257(1-2):23-31. doi: 10.1016/j.cellimm.2009.02.002.

PMID:
19306994
16.

Flow cytometry-based assay for determination of teleost cytotoxic cell lysis of target cells.

Oumouna M, Jaso-Friedmann L, Evans DL.

Cytometry. 2001 Dec 1;45(4):259-66.

PMID:
11746095
17.

Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo.

Rau H, Revets H, Balmelli C, McCullough KC, Summerfield A.

Vet Res. 2006 Jan-Feb;37(1):155-68.

18.

Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs.

Aloysius MM, Mc Kechnie AJ, Robins RA, Verma C, Eremin JM, Farzaneh F, Habib NA, Bhalla J, Hardwick NR, Satthaporn S, Sreenivasan T, El-Sheemy M, Eremin O.

J Transl Med. 2009 Mar 19;7:18. doi: 10.1186/1479-5876-7-18.

19.
20.

Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumor.

Dosset M, Godet Y, Vauchy C, Beziaud L, Lone YC, Sedlik C, Liard C, Levionnois E, Clerc B, Sandoval F, Daguindau E, Wain-Hobson S, Tartour E, Langlade-Demoyen P, Borg C, Adotévi O.

Clin Cancer Res. 2012 Nov 15;18(22):6284-95. doi: 10.1158/1078-0432.CCR-12-0896. Epub 2012 Oct 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk